When we think of bioidentical hormone replacement therapy, we think of a compounding pharmacy. However, Christopher Shade, PhD, proposes a new strategy to help practitioners help their female patients with perimenopausal and menopausal issues. Dr. Shade has developed a non-prescription protocol that can specifically address the variety of symptoms of perimenopause, menopause, and post menopause. In this interview, he explains the science behind his approach.
Simple and Relaxing Minimal Ambient" by Coma-Media and “Inspirational Background” by AudioCoffee via pixabay.com.
Approximate listening time: 30 minutes
About the Expert
Christopher Shade, PhD, is founder and CEO of Quicksilver Scientific. Shade’s vast depth and breadth of knowledge, passion for healing, and intuitive understanding of chemistry and biology are reflected in Quicksilver Scientific’s well-designed detoxification protocols, unique supplement delivery systems, and patented mercury speciation test.
Shade earned his PhD from the University of Illinois Urbana-Champaign and his undergraduate degree in Environmental Chemistry is from Lehigh University. He is a recognized expert on mercury and liposomal delivery systems. He has lectured and trained doctors in the US and internationally on the subject of mercury, heavy metals, and the human detoxification system. Shade's current focus is on the development of cutting-edge, lipid-based delivery systems for nutraceuticals to address the growing need for high-quality, affordable detoxification solutions.
About the Sponsor
Quicksilver Scientific, Inc. is a leading manufacturer of premium nutraceuticals. Our mission: combine nature's nutrients with innovative science to empower people’s health journey. We’ve pioneered a holistic solution to meet any modern health goal: testing that identifies toxicity levels; professional protocols that detoxify the body; and an evolving line of liposomal supplements. Quicksilver Scientific’s advanced nanoparticle technology has resulted in a premier and sophisticated delivery system — solving the industry’s “bioavailability problem” by sending the highest-quality nutrients into the cells for more direct absorption
